Immunological evaluation of patients with recurrent abortion
Journal of Reproductive Immunology, ISSN: 0165-0378, Vol: 56, Issue: 1, Page: 111-121
2002
- 46Citations
- 16Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations46
- Citation Indexes46
- 46
- CrossRef40
- Captures16
- Readers16
- 16
Article Description
In a prospective study, we performed immunological tests in patients with recurrent abortion. Nine couples with two or more fetal losses of no apparent cause were selected as the patient group, and nine volunteer couples with at least two children and without a history of abortion were used as controls. The frequency of major histocompatibility complex (human leukocyte antigens, HLA) antigen sharing was determined by serological methods, antipaternal antibodies by microlymphocytotoxicity, lymphocyte phenotypes (CD4, CD8, CD19, CD16, CD56 and HLA-DR positive cells) by flow cytometry and natural killer (NK) cytotoxicity by 51 Cr release. NK activity was correlated to the degree of HLA-C sharing and to the percentage of CD16+ and CD56+ cells and to progesterone levels measured by radioimmunoassay. No difference in class I or class II HLA antigen sharing was detected between couples with and without recurrent abortion. Antipaternal antibodies were not found in the serum of any woman of the study. A higher absolute number of CD8+ cells ( P =0.01) and a trend to increased CD19+ cells ( P =0.05) were observed among patients. NK activity did not differ between the two groups when expressed as specific cytotoxicity and it was reduced among patients with recurrent abortion when expressed as lytic units/10 7 cells ( P =0.04). There was correlation between NK activity and the percentage of CD16+ and CD56+ cells but not with progesterone levels in patients with recurrent abortion. Our data suggest that an increased NK activity may not play a role in the occurrence of repeated abortion. On the other hand, an increase in circulating CD8+ T cells was observed in patients suggesting that antifetal cytotoxicity in recurrent abortion may be mediated by T cells and not by NK cells.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0165037801001450; http://dx.doi.org/10.1016/s0165-0378(01)00145-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0036308467&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12106887; http://linkinghub.elsevier.com/retrieve/pii/S0165037801001450; http://api.elsevier.com/content/article/PII:S0165037801001450?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0165037801001450?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0165037801001450; http://dx.doi.org/10.1016/s0165-0378%2801%2900145-0; https://dx.doi.org/10.1016/s0165-0378%2801%2900145-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know